Anticancer potential of turmeric (Curcuma longa) ethanol extract and prediction of its mechanism through the Akt1 pathway
Open Access
- 6 September 2022
- journal article
- research article
- Published by F1000 Research Ltd in F1000Research
- Vol. 11, 1000
Abstract
Background: Turmeric (Curcuma longa) has high potential as a traditional anticancer drug. This study aimed to analyze the anticancer activity of turmeric ethanol extract on T47D cells and examine the interaction of Akt1 protein with compounds contained in turmeric. Methods: The cytotoxicity assay was conducted using WST-1 reagents. Apoptosis assay used annexin V-PI, whereas cell cycle assay used PI, and then the results were analyzed using a flow cytometer. LC-HRMS analysis was conducted to identify the active compounds. Docking between Akt1 and ligands was performed using Autodock 4.2 software. Molecular dynamics simulations were conducted using YASARA with a time parameter of 20 ns, pH 7.4, and 37°C. Results: The extract had a strong toxicity on T47D cells (cytotoxicity IC50 value: 26.36 ± 1.55 µg/mL). The extract induced apoptosis of T47D cells at the IC50 dose (~30% cells) and induced the cell cycle arrest in G1 phase. Curcumin, 2-hydroxycinnamic acid and caryophyllene oxide had lower binding energy into Akt1 than AZD5363 used as a positive control. Curcumin, Ar-turmerone, and α-curcumene bind in the ATP binding pocket of Akt1, so the compounds have a high potential to be an ATP-competitive Akt1 inhibitors. The interaction of Akt1 with the compound contained in turmeric had an RMSD backbone value that was more stable than that of ATP and AZD5363. Root-mean-square fluctuation values indicated that amino acid residues that had an essential role in ligand binding sites were stable during simulation. Conclusions: The turmeric ethanol extract had a potential anti-cancer effect by inducing apoptosis and inhibiting cell cycle progression on T47D cells. The docking analysis showed that the active compounds of the extract, such as curcumin, Ar-turmerone, caryophyllene oxide, and α-curcumene, were able to bind into the ATP binding pocket of Akt1 that might inhibit the protein activity and induce cell cycle arrest.Keywords
Funding Information
- Kementerian Riset dan Teknologi /Badan Riset dan Inovasi Nasional (023/E4.1/AK.04.PT/2021)
This publication has 73 references indexed in Scilit:
- Hydroxycinnamic Acid Antioxidants: An Electrochemical OverviewBioMed Research International, 2013
- Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer CellsFrontiers in Oncology, 2013
- Aromatic‐turmerone attenuates invasion and expression of MMP‐9 and COX‐2 through inhibition of NF‐κB activation in TPA‐induced breast cancer cellsJournal of Cellular Biochemistry, 2012
- An ATP-Site On-Off Switch That Restricts Phosphatase Accessibility of AktScience Signaling, 2012
- β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activationCancer Letters, 2011
- Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinomaMolecular Cancer, 2011
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Cytotoxic activity screening of some indigenous Thai plantsFitoterapia, 2008
- Immunomodulatory effects of curcumin: In-vivoInternational Immunopharmacology, 2008
- Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitorsBiochemical Journal, 2005